CHRU de Lille - Hopital Claude Huriez - Maladies du Sang

Lille 59037

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling